The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interrogating resistance mechanisms to PD-1 blockade therapy with CRISPR.
 
Davis Yuri Torrejon
No Relationships to Disclose
 
Jesse Meir Zaretsky
No Relationships to Disclose
 
Daniel Sanghoon Shin
No Relationships to Disclose
 
Mykola Onyshchenko
No Relationships to Disclose
 
Gabriel Abril-Rodriguez
No Relationships to Disclose
 
Agustin Vega-Crespo
No Relationships to Disclose
 
Cristina Puig-Saus
No Relationships to Disclose
 
Gardenia Cheung-Lau
No Relationships to Disclose
 
Chris Long
No Relationships to Disclose
 
Begonya Comin-Anduix
No Relationships to Disclose
 
Siwen Hu-Lieskovan
Honoraria - Amgen; Emergent BioSolutions; Merck; Novartis; Vaccinex
Consulting or Advisory Role - Amgen; Emergent BioSolutions; Merck; Novartis; Vaccinex
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Plexxikon (Inst)
 
Antoni Ribas
Stock and Other Ownership Interests - Arcus Ventures; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis